Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Sleep Initiation and Maintenance Disorders 1Multiple Endocrine Neoplasia Type 1 1Hot Flashes 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × zopiclone × Clear all
NCT06219902 2024-05-08

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Bayer

Phase 1 Completed
64 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT02807922 2021-07-16

Pharmacological Treatment of Insomnia in Palliative Care

St. Olavs Hospital

Phase 4 Completed
43 enrolled

Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡